DNA electroporation prime and protein boost strategy enhances humoral immunity of tuberculosis DNA vaccines in mice and non-human primates

Vaccine

Volumn 24, Issue 21, 2006, Pages 4565-4568

  Li, Zhongming ^a   Zhang, Hongyong ^b   Fan, Xiaoyong ^a   Zhang, Ying ^a   Huang, Jialu ^a   Liu, Qingliang ^a   Tjelle, Torunn Elisabeth ^c   Mathiesen, Iacob ^c   Kjeken, Rune ^c   Xiong, Sidong ^b  

^a HG   (Netherlands)

^b FUDAN UNIVERSITY   (China)

^c Inovio AS   (Norway)

Author keywords

Electroporation; Humoral immunity; Non human primates; Prime boost; Tuberculosis DNA vaccines

Indexed keywords

BACTERIAL ANTIGEN; DNA VACCINE; EARLY SECRETORY ANTIGENIC TARGET 6; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG MECHANISM; FEMALE; HUMORAL IMMUNITY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUBERCULOSIS; VACCINATION;

ANIMALS; ANTIBODIES, VIRAL; ELECTROPORATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; MICE; PRIMATES; VACCINES, DNA;

EID: 33747135384     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2005.08.021     Document Type: Article

References (11)

1. Donnelly J.J., Ulmer J.B., Shiver J.W., and Liu M.A. DNA vaccines. Annu Rev Immunol 15 (1997) 617-648
2. Huygen K., Content J., Denis O., Montgomery D.L., Yawman A.M., Deck R.R., et al. Immunogenicity and protective efficacy of a tuberculosis DNA vaccine. Nat Med 2 (1996) 893-898
3. Scheerlinck J.P.Y., Karlis J., Tjelle T.E., Presidente P.J.A., Mathuesen I., and Newton S.E. In vivo electroporation imorove immune responses to DNA vaccination in sheep. Vaccine 22 (2004) 1820-1825
4. Mathiesen I. Electropermeabilization of skeletal muscle enhances gene transfer in vivo. Gene Ther 6 (1999) 508-514
5. Widera G., Austin M., Rabussay D., Goldbeck C., Barnett S.W., Chen M., et al. Increased DNA vaccine delivery and immunogenicity by electroporation in vivo. J Immunol 164 (2000) 4635-4640
6. Andersen P. Effective vaccination of mice against Mycobacterium tuberculosis infection with a soluble mixture of secreted mycobacterial proteins. Infect Immun 62 (1994) 2536-2544
7. Schuh T., Schultz J., Moelling K., and Pavlovic J. DNA-based vaccine against La Crosse virus: protective immune response mediated by neutralizing antibodies and CD4+ T cells. Hum Gene Ther 10 (1999) 1649-1658
8. Gu M.L., Leppla S.H., and Klinman D.M. Protection against anthrax toxin by vaccination with a DNA plasmid encoding anthrax protective antigen. Vaccine 17 (1999) 340-344
9. Gronevik E., Tollefsen S., Sikkeland L.I., Haug T., Tjelle T.E., and Mathiesen I. DNA transfection of mononuclear cells in muscle tissue. J Gene Med 10 (2003) 909-917
10. Tollefsen S., Tjelle T., Schneider J., Harboe M., Wiker H., Hewinson G., et al. Improved cellular and humoral immune responses against Mycobacterium tuberculosis antigens after intramuscular DNA immunisation combined with muscle electroporation. Vaccine 20 (2002) 3370-3378
11. Tanghe A., D'Souza S., Rosseels V., Denis O., Ottenhoff T.H.M., Dalemans W., et al. Improved immunogenicity and protective efficacy of a tuberculosis DNA vaccine encoding Ag85 by protein boosting. Infect Immun 69 (2001) 3041-3047